Latest News: Proscia Receives FDA 510(k) Clearance For Concentriq AP-DxREAD THE PRESS RELEASE

Where We Stand in Realizing the Promise of Digital Pathology

Proscia
By Author Proscia | April 9, 2021

In this contributed piece, Proscia’s Chief Medical Officer Dr. Mike Bonham explores how COVID has accelerated digital pathology adoption as laboratories’ ability to operate has increasingly become tied to their digital footprint. In doing so, it has also laid the foundation for laboratories to realize the benefits of the digital transformation beyond remote work, positioning them to meet future challenges and capitalize on the opportunity ahead.

Our website uses cookies. By using this site, you agree to its use of cookies.